Treatment
FDA Approves Ketamine for Treatment-Resistant Depression
Yesterday, on March 5, 2019, the FDA approved the use of ketamine for treatment-resistant depression. The new drug Spravato is a nasal spray that will
March 6, 2019
No Comments